NASDAQ:TKNO
Alpha Teknova, Inc. Stock News
$1.79
-0.110 (-5.79%)
At Close: May 17, 2024
Teknova to Report Second Quarter 2023 Financial Results on August 10, 2023
08:00am, Wednesday, 26'th Jul 2023
HOLLISTER, Calif., July 26, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization o
Teknova Expands Proprietary AAV-Tek™ Solutions Product Line to Deliver End-to-End Solutions for Gene Therapy Process Development
08:00am, Tuesday, 11'th Jul 2023
First-of-its-kind screening kit now available for AAV8 – along with a suite of high-quality reagents to support the entire AAV workflow – helping gene therapy developers save months in process dev
Teknova to Participate in Upcoming Investor Conference
08:00am, Thursday, 25'th May 2023
HOLLISTER, Calif., May 25, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and commercial
Alpha Teknova, Inc. (TKNO) Q1 2023 Earnings Call Transcript
01:57pm, Saturday, 13'th May 2023
Alpha Teknova, Inc. (NASDAQ:TKNO ) Q1 2023 Earnings Conference Call May 10, 2023 5:30 PM ET Company Participants Jennifer Henry - Senior Vice President of Marketing Stephen Gunstream - President & Chi
Teknova to Present Data on Novel Products to Accelerate the Development of AAV Therapies at ASGCT 2023 Annual Meeting
08:00am, Wednesday, 10'th May 2023
Company will share their latest findings for custom product innovations aimed at addressing key gene therapy bioprocessing bottlenecks Company will share their latest findings for custom product innov
Teknova to Report First Quarter 2023 Financial Results on May 10, 2023
08:00am, Wednesday, 26'th Apr 2023
HOLLISTER, Calif., April 26, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and commerci
Down -48.43% in 4 Weeks, Here's Why You Should You Buy the Dip in Alpha Teknova (TKNO)
10:42am, Friday, 07'th Apr 2023
Alpha Teknova (TKNO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revi
Alpha Teknova, Inc. (TKNO) Q4 2022 Earnings Call Transcript
08:04pm, Wednesday, 15'th Mar 2023
Alpha Teknova, Inc. (NASDAQ:TKNO ) Q4 2022 Results Conference Call March 15, 2023 5:00 PM ET Company Participants Jen Henry - Senior Vice President of Marketing Stephen Gunstream - President & Chief E
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month - Cara Therapeutics (NASDAQ:CARA), AdaptHealth (NASDAQ:AHCO)
08:02am, Tuesday, 14'th Mar 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Teknova to Participate in Upcoming Investor Conferences
08:00am, Friday, 10'th Feb 2023
HOLLISTER, Calif., Feb. 10, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and commercia
Alpha Teknova, Inc. (TKNO) Q3 2022 Earnings Call Transcript
04:42am, Sunday, 13'th Nov 2022
Alpha Teknova, Inc. (NASDAQ:TKNO ) Q3 2022 Earnings Conference Call November 21, 2022 4:30 PM ET Company Participants Jennifer Henry - Senior Vice President of Marketing Stephen Gunstream - President
Teknova to Participate in Upcoming Investor Conferences
04:01pm, Thursday, 03'rd Nov 2022
HOLLISTER, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the discovery, research, development, and commercia
Teknova to Report Third Quarter 2022 Financial Results on November 9, 2022
04:01pm, Wednesday, 26'th Oct 2022
HOLLISTER, Calif., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the discovery, development, and commercialization o
Teknova to Participate in Upcoming Investor Conference
04:01pm, Wednesday, 31'st Aug 2022
HOLLISTER, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the discovery, development, and commercialization o
Alpha Teknova, Inc. (TKNO) CEO Stephen Gunstream on Q2 2022 Results - Earnings Call Transcript
07:43pm, Wednesday, 10'th Aug 2022
Alpha Teknova, Inc. (NASDAQ:TKNO ) Q2 2022 Earnings Conference Call August 10, 2022 4:30 PM ET Company Participants Sara Michelmore - Head of Investor Relations, MacDougall Advisors Stephen Gunstream